Loading...
Minimal clinically important difference in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease with an estimated median survival of 2–5 years and a significant impact on quality of life (QoL). Current approved medications, pirfenidone and nintedanib, have shown a reduction in annual decline of forced vital ca...
Saved in:
| Published in: | Breathe (Sheff) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
European Respiratory Society
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8291912/ https://ncbi.nlm.nih.gov/pubmed/34295421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0345-2020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|